FDA Approval Decisions Report
September, 2008
| Date: | Sep 01, 2008 |
|---|---|
| Format: | |
| View Report » |
Abstract
The Revere FDA Approval Decision Report provides one of the most comprehensive and accurate event calendars for PDUFA dates (Prescription Drug User Fee Act) - expected FDA approval dates for NDA/BLA filed drugs. In particular, this report identifies Biotech/Pharmaceutical companies with expected FDA approvals in the next 3 months and reviews all FDA approval decisions in the current month. Furthermore, the report also analyzes each drug candidate's likelihood of approval and competitive landscape using 3 criteria derived from Revere's patented classification system: (1) Utilization of a mechanism of action previously approved by the FDA, (2) Facing two or fewer alternative drugs with the same mechanism of action for the same indication, and (3) Would be the first or second FDA approved drug for the company. Original, unbiased, insightful and actionable, the Revere FDA Approval Decision Report is an indispensable tool for successful Biotech/Pharmaceutical investing.
Companies Mentioned in the Report
- Abbott Laboratories (ABT) - Overview - Reports
- AMAG Pharmaceuticals, Inc. (AMAG) - Overview - Reports
- Barr Pharmaceuticals Inc (?203155) - Overview - Reports
- Cephalon Inc (?204110) - Overview - Reports
- Cypress Bioscience, Inc. (?206025) - Overview - Reports
- Eli Lilly & Co. (LLY) - Overview - Reports
- Enzon Pharmaceuticals, Inc. (ENZN) - Overview - Reports
- Forest Laboratories, Inc. (FRX) - Overview - Reports
- Genentech, Inc. (?248964) - Overview - Reports
- General Electric Co (GE) - Overview - Reports
- Gilead Sciences, Inc. (GILD) - Overview - Reports
- GlaxoSmithKline plc (ADR) (GSK) - Overview - Reports
- Nektar Therapeutics (NKTR) - Overview - Reports
- Johnson & Johnson (JNJ) - Overview - Reports
- K-V Pharmaceutical Company (KV/B) - Overview - Reports
- Ligand Pharmaceuticals Inc. (LGND) - Overview - Reports
- Novartis AG (ADR) (NVS) - Overview - Reports
- OSI Pharmaceuticals, Inc. (CH716923BCN8001:MSTAR:US) - Overview - Reports
- Pfizer Inc. (PFE) - Overview - Reports
- Pharmaceutical Product Development Inc (?218819) - Overview - Reports
- Watson Pharmaceuticals, Inc. (WPI) - Overview - Reports
- AstraZeneca plc (ADR) (AZN) - Overview - Reports
- Eisai Co., Ltd (ADR) (ESALY) - Overview - Reports
- Roche Holding AG (RHHBY) - Overview - Reports
- Gen-Probe Incorporated (GPRO) - Overview - Reports
- Salix Pharmaceuticals, Ltd. (SLXP) - Overview - Reports
- Cipher Pharmaceuticals Inc (CPHMF) - Overview - Reports
- BioDelivery Sciences International, Inc. (BDSI) - Overview - Reports
- Novadel Pharma Inc (NVDL) - Overview - Reports
- Takeda Yakuhin Kogyo KK (TKPYY) - Overview - Reports
More Information:
Learn more about FDA Approval Decisions Report.